ZNF516 suppresses EGFR by targeting the CtBP/LSD1/CoREST complex to chromatin

[1]  S. Nagini,et al.  Breast Cancer: Current Molecular Therapeutic Targets and New Players. , 2017, Anti-cancer agents in medicinal chemistry.

[2]  H. Sul,et al.  LSD1 Interacts with Zfp516 to Promote UCP1 Transcription and Brown Fat Program. , 2016, Cell reports.

[3]  Stephen L. Abrams,et al.  Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for Therapy. , 2016, Current pharmaceutical design.

[4]  I. Alanazi,et al.  Understanding EGFR Signaling in Breast Cancer and Breast Cancer Stem Cells: Overexpression and Therapeutic Implications. , 2016, Asian Pacific journal of cancer prevention : APJCP.

[5]  A. Appert-Collin,et al.  Role of ErbB Receptors in Cancer Cell Migration and Invasion , 2015, Front. Pharmacol..

[6]  D. Greenberg,et al.  Spotting the enemy within: Targeted silencing of foreign DNA in mammalian genomes by the Krüppel-associated box zinc finger protein family , 2015, Mobile DNA.

[7]  Qing-Yu He,et al.  ChIPseeker: an R/Bioconductor package for ChIP peak annotation, comparison and visualization , 2015, Bioinform..

[8]  Zhuang Wei,et al.  Screening of candidate genes in fibroblasts derived from patients with Dupuytren’s contracture using bioinformatics analysis , 2015, Rheumatology International.

[9]  H. Sul,et al.  Cold-inducible Zfp516 activates UCP1 transcription to promote browning of white fat and development of brown fat. , 2015, Molecular cell.

[10]  Brian David Dynlacht,et al.  Foxk proteins repress the initiation of starvation-induced atrophy and autophagy programs , 2014, Nature Cell Biology.

[11]  X. Li,et al.  GATA3 cooperates with PARP1 to regulate CCND1 transcription through modulating histone H1 incorporation , 2014, Oncogene.

[12]  R. Irizarry,et al.  Genome-wide methylation profiling reveals Zinc finger protein 516 (ZNF516) and FK-506-binding protein 6 (FKBP6) promoters frequently methylated in cervical neoplasia, associated with HPV status and ethnicity in a Chilean population , 2014, Epigenetics.

[13]  Lei Zhou,et al.  The Malignant Brain Tumor (MBT) Domain Protein SFMBT1 Is an Integral Histone Reader Subunit of the LSD1 Demethylase Complex for Chromatin Association and Epithelial-to-mesenchymal Transition* , 2013, The Journal of Biological Chemistry.

[14]  C. Haldeman-Englert,et al.  Narrowing the Critical Region for Congenital Vertical Talus in Patients With Interstitial 18q Deletions , 2013, American journal of medical genetics. Part A.

[15]  Hui Shen,et al.  Gene‐gene interaction between RBMS3 and ZNF516 influences bone mineral density , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  Jiri Bartek,et al.  Replication stress links structural and numerical cancer chromosomal instability , 2013, Nature.

[17]  C. Perou,et al.  Genome-wide profiles of CtBP link metabolism with genome stability and epithelial reprogramming in breast cancer , 2013, Nature Communications.

[18]  Yong Zhang,et al.  Identifying ChIP-seq enrichment using MACS , 2012, Nature Protocols.

[19]  O. Maksimenko,et al.  Cys2His2 zinc finger protein family: Classification, functions, and major members , 2012, Biochemistry (Moscow).

[20]  G. Giovinazzo,et al.  Resveratrol inhibits the epidermal growth factor-induced epithelial mesenchymal transition in MCF-7 cells. , 2011, Cancer letters.

[21]  Jiong Wu,et al.  TIEG1 Inhibits Breast Cancer Invasion and Metastasis by Inhibition of Epidermal Growth Factor Receptor (EGFR) Transcription and the EGFR Signaling Pathway , 2011, Molecular and Cellular Biology.

[22]  Philip Machanick,et al.  MEME-ChIP: motif analysis of large DNA datasets , 2011, Bioinform..

[23]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[24]  William Stafford Noble,et al.  FIMO: scanning for occurrences of a given motif , 2011, Bioinform..

[25]  L. Carey,et al.  Triple-negative breast cancer: disease entity or title of convenience? , 2010, Nature Reviews Clinical Oncology.

[26]  Yi-shuian Huang,et al.  A novel role of CPEB3 in regulating EGFR gene transcription via association with Stat5b in neurons , 2010, Nucleic acids research.

[27]  Luyang Sun,et al.  LSD1 Is a Subunit of the NuRD Complex and Targets the Metastasis Programs in Breast Cancer , 2009, Cell.

[28]  M. Walsh,et al.  The ZNF217 oncogene is a candidate organizer of repressive histone modifiers , 2009, Epigenetics.

[29]  Yixue Li,et al.  SysZNF: the C2H2 zinc finger gene database , 2008, Nucleic Acids Res..

[30]  Cole Trapnell,et al.  Ultrafast and memory-efficient alignment of short DNA sequences to the human genome , 2009, Genome Biology.

[31]  P. Wright,et al.  RIP1 links inflammatory and growth factor signaling pathways by regulating expression of the EGFR , 2008, Cell Death and Differentiation.

[32]  R. Kornberg.  The molecular basis of eukaryotic transcription , 2007, Proceedings of the National Academy of Sciences.

[33]  B. Brandt,et al.  Mechanisms of egfr Gene Transcription Modulation: Relationship to Cancer Risk and Therapy Response , 2006, Clinical Cancer Research.

[34]  Min Gyu Lee,et al.  Functional Interplay between Histone Demethylase and Deacetylase Enzymes , 2006, Molecular and Cellular Biology.

[35]  Michael R. Green,et al.  Transcriptional regulatory elements in the human genome. , 2006, Annual review of genomics and human genetics.

[36]  M. Nardini,et al.  Specific Recognition of ZNF217 and Other Zinc Finger Proteins at a Surface Groove of C-Terminal Binding Proteins , 2006, Molecular and Cellular Biology.

[37]  W. Gullick,et al.  The Role of the Epidermal Growth Factor Receptor in Breast Cancer , 2006, Journal of Mammary Gland Biology and Neoplasia.

[38]  John Mendelsohn,et al.  Epidermal growth factor receptor targeting in cancer. , 2006, Seminars in oncology.

[39]  Min Gyu Lee,et al.  An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation , 2005, Nature.

[40]  Jin-Yuan Shih,et al.  EGFR mutation conferring primary resistance to gefitinib in non-small-cell lung cancer. , 2005, The New England journal of medicine.

[41]  P. Jänne,et al.  Epidermal growth factor receptor mutations in non-small-cell lung cancer: implications for treatment and tumor biology. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  T. Smart,et al.  HEK293 cell line: a vehicle for the expression of recombinant proteins. , 2005, Journal of pharmacological and toxicological methods.

[43]  R. Clarke.  Human breast cancer cell line xenografts as models of breast cancer — The immunobiologies of recipient mice and the characteristics of several tumorigenic cell lines , 2005, Breast Cancer Research and Treatment.

[44]  M. Nardini,et al.  CtBP/BARS: a dual‐function protein involved in transcription co‐repression and Golgi membrane fission , 2003, The EMBO journal.

[45]  Yang Shi,et al.  Coordinated histone modifications mediated by a CtBP co-repressor complex , 2003, Nature.

[46]  N. Hynes,et al.  The ErbB receptors and their role in cancer progression. , 2003, Experimental cell research.

[47]  R. Nicholson,et al.  EGFR and cancer prognosis. , 2001, European journal of cancer.

[48]  M. Kurokawa,et al.  The corepressor CtBP interacts with Evi-1 to repress transforming growth factor beta signaling. , 2001, Blood.

[49]  S. Schreiber,et al.  CoREST is an integral component of the CoREST- human histone deacetylase complex. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[50]  J. Schlessinger.  Cell Signaling by Receptor Tyrosine Kinases , 2000, Cell.

[51]  G. Thomas,et al.  The human T-cell transcription factor-4 gene: structure, extensive characterization of alternative splicings, and mutational analysis in colorectal cancer cell lines. , 2000, Cancer research.

[52]  G. Thomas,et al.  Frequent frameshift mutations of the TCF-4 gene in colorectal cancers with microsatellite instability. , 1999, Cancer research.

[53]  D. Dean,et al.  ZEB represses transcription through interaction with the corepressor CtBP. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[54]  S. Deb,et al.  Transcriptional activation of the human epidermal growth factor receptor promoter by human p53 , 1996, Molecular and cellular biology.

[55]  Kerstin Sollerbrant,et al.  The CtBP binding domain in the adenovirus E1A protein controls CR1- dependent transactivation , 1996, Nucleic Acids Res..

[56]  J. M. Boyd,et al.  Molecular cloning and characterization of a cellular phosphoprotein that interacts with a conserved C-terminal domain of adenovirus E1A involved in negative modulation of oncogenic transformation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[57]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[58]  A. Johnson,et al.  Identification of an epidermal growth factor receptor transcriptional repressor. , 1994, The Journal of biological chemistry.

[59]  J. M. Boyd,et al.  A region in the C‐terminus of adenovirus 2/5 E1a protein is required for association with a cellular phosphoprotein and important for the negative modulation of T24‐ras mediated transformation, tumorigenesis and metastasis. , 1993, The EMBO journal.

[60]  L. Goldsmith,et al.  Transcriptional control of epidermal growth factor receptor by retinoic acid. , 1992, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[61]  J. Hein.  Unified approach to alignment and phylogenies. , 1990, Methods in enzymology.

[62]  I. Pastan,et al.  Molecular cloning and characterization of a human DNA binding factor that represses transcription , 1989, Cell.

[63]  G. Chinnadurai,et al.  Enhanced ras oncogene mediated cell transformation and tumorigenesis by adenovirus 2 mutants lacking the C-terminal region of E1a protein. , 1989, Oncogene.

[64]  I. Pastan,et al.  A transcription factor active on the epidermal growth factor receptor gene. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[65]  A. Ullrich,et al.  Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences , 1984, Nature.